XML 34 R10.htm IDEA: XBRL DOCUMENT v3.20.1
Accounts Receivable
3 Months Ended
Mar. 31, 2020
Receivables [Abstract]  
Accounts Receivable
Accounts Receivable

As of March 31, 2020 and December 31, 2019, the Company had accounts receivable of $4.2 million and $7.2 million respectively, which relates to royalty revenue from the sales of NARCAN®.